| Previous Close | 56.14 |
| Open | 56.01 |
| Bid | 56.61 x 28400 |
| Ask | 56.62 x 2100 |
| Day's Range | 55.80 - 56.86 |
| 52 Week Range | 44.85 - 78.34 |
| Volume | 618,673 |
| Avg. Volume | 3,794,720 |
| Market Cap | 55.615B |
| Beta (5Y Monthly) | 1.30 |
| PE Ratio (TTM) | 12.82 |
| EPS (TTM) | 4.42 |
| Earnings Date | Nov. 03, 2020 |
| Forward Dividend & Yield | 2.80 (4.91%) |
| Ex-Dividend Date | Apr. 29, 2020 |
| 1y Target Est | 120.99 |
- Zacks
Regeneron's (REGN) Q2 Earnings & Sales Surpass Estimates
Regeneron (REGN) beats on Q2 earnings and sales on solid performance of Dupixent and oncology drug, Libtayo.
- Reuters
GLOBAL MARKETS-Asia shares poised to open lower, gold at fresh record
Asia shares were set to open lower on Wednesday, following a choppy trading session on Wall Street and losses in Europe. Nikkei futures were trading 0.3% below the Nikkei 225 index's previous close. Wall Street shares ended higher after choppy trade as hopes mounted U.S. leaders would agree on another coronavirus stimulus package.
- Reuters
GLOBAL MARKETS-Gold soars past $2,000, gold up on stimulus plan
Gold surged past the $2,000 mark on Tuesday after Democrats and the White House appeared closer to agreement on new stimulus to help the coronavirus-hit economy while stocks on Wall Street ended higher as investors awaited more aid from Washington. Oil prices also rose on the prospect of more stimulus but Treasury yields fell to their lowest since March on safe-haven demand and concerns about the ultimate cost of aid. Gold prices breached the psychological $2,000 level for the first time, propelled by stimulus concerns.
